Nippon Life Global Investors Americas Inc. bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 112,890 shares of the company's stock, valued at approximately $3,597,000. Nippon Life Global Investors Americas Inc. owned approximately 0.07% of Option Care Health as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently bought and sold shares of the company. V Square Quantitative Management LLC acquired a new position in Option Care Health during the fourth quarter worth $25,000. Cornerstone Planning Group LLC boosted its holdings in Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after purchasing an additional 1,067 shares during the last quarter. Advisory Services Network LLC acquired a new position in Option Care Health during the third quarter worth $35,000. McIlrath & Eck LLC acquired a new position in Option Care Health during the second quarter worth $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the third quarter worth $38,000. Institutional investors own 98.05% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on OPCH. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley increased their price target on shares of Option Care Health from $35.00 to $38.00 and gave the company an "overweight" rating in a research note on Tuesday, January 13th. Weiss Ratings reiterated a "hold (c)" rating on shares of Option Care Health in a research note on Monday, December 29th. Truist Financial set a $40.00 price target on shares of Option Care Health in a research note on Tuesday, January 13th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $37.27.
Check Out Our Latest Analysis on OPCH
Option Care Health Price Performance
Shares of OPCH opened at $28.40 on Monday. The firm has a market capitalization of $4.46 billion, a PE ratio of 22.19, a PEG ratio of 1.59 and a beta of 0.95. The company's 50-day moving average is $29.93 and its 200-day moving average is $30.78. Option Care Health, Inc. has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company's revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 earnings per share. Equities analysts forecast that Option Care Health, Inc. will post 1.69 EPS for the current year.
Option Care Health Profile
(
Free Report)
Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.
See Also
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
